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Healthcare providers were rapidly forced to modify the way they practiced medicine
during the coronavirus disease 2019 (COVID-19) pandemic. Many providers transitioned
from seeing their patients in person to virtually using telemedicine platforms with
limited training and experience using this medium. In pediatric rheumatology, this was
further complicated as musculoskeletal exams typically require hands-on assessment
of patients. The objective of this study was to examine the adoption of telemedicine
into pediatric rheumatology practices, to assess its benefits and challenges, and to
gather opinions on its continued use. A survey was sent to the lead representatives of
each Pediatric Rheumatology Care and Outcomes Improvement Network (PR-COIN) site
to collect data about their center’s experience with telemedicine during the COVID-19
pandemic. Quantitative data were analyzed using descriptive statistics, and qualitative
data were thematically analyzed. Responses were received from the majority [19/21
(90%)] of PR-COIN sites. All respondents reported transitioning from in-person to
primarily virtual patient visits during the COVID-19 pandemic. All centers reported seeing
both new consultations and follow-up patients over telemedicine. Most centers reported
using both audio and video conferencing systems to conduct their telemedicine visits.
The majority of respondents [13/19 (68%)] indicated that at least 50% of their site’s
providers consistently used pediatric Gait Arms Legs and Spine (pGALS) to perform
active joint count assessments over telemedicine. Over half of the centers [11/19
(58%)] reported collecting patient-reported outcomes (PROs), but the rate of reliably
documenting clinical components varied. A few sites [7/19 (37%)] reported performing
research-related activity during telemedicine visits. All centers thought that telemedicine
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visits were able to meet providers’ needs and support their continued use when the
pandemic ends. Benefits reported with telemedicine visits included convenience and
continuity of care for families. Conversely, challenges included limited ability to perform
physical exams and varying access to technology. Pediatric rheumatology providers were
able to transition to conducting virtual visits during the COVID-19 pandemic. Healthcare
providers recognize how telemedicine can enhance their practice, but challenges
need to be overcome in order to ensure equitable, sustainable delivery of quality and
patient-centered care.
Keywords: telemedicine, pediatric rheumatology, telehealth, COVID-19, virtual platform, digital health (eHealth),
health services research, virtual care

INTRODUCTION

disease activity assessment performed by their local Advanced
Clinician Practitioner in Arthritis Care (ACPAC) practitioner
(10, 18). Decreased cost and burden associated with travel, as
well as increased access to care and patient satisfaction, were
noted (10).
The COVID-19 pandemic forced healthcare providers,
including pediatric rheumatology providers, to rapidly shift to
virtual care. Many of the previous barriers to telemedicine,
such as reimbursement and regulatory concerns, were abruptly
lifted to allow for its accelerated adoption (19). The practice of
telemedicine facilitated uninterrupted medical care while abiding
by physical distancing requirements. The forced, expedited
adoption of telemedicine across pediatric rheumatology clinics
came with its challenges. The recognition of these challenges
and barriers prompts the identification of potential solutions
that will improve future delivery of care over telemedicine.
The objective of this study was to examine the adoption of
telemedicine into pediatric rheumatology practices during the
COVID-19 pandemic, to assess its benefits and challenges, and
to gather opinions on its continued use.

The coronavirus disease 2019 (COVID-19) pandemic triggered
an international call for physical distancing, which limited
patients’ access to healthcare. As a result, healthcare providers
explored telemedicine as an alternative or complementary
method of delivering medical care (1, 2). The pediatric
population, specifically those with chronic diseases, have higher
medical needs, necessitating frequent visits to their medical
provider (3). Due to the nature of their underlying diseases
and treatment with immunosuppressive medications, children
with rheumatic conditions require ongoing medical care for both
physical exam assessment and laboratory studies (3).
Limited access to pediatric rheumatology care is an established
issue, which is further exacerbated by the shortage of providers
(4). Although there was little infrastructure to support virtual
visits, telemedicine was proposed as a solution to improving
access to pediatric rheumatologists prior to the COVID-19
pandemic (5–7). While previous telemedicine studies in other
areas of medicine including adult rheumatology have shown
promise, there are limited published reports regarding its use
in the pediatric rheumatology setting (8–12). Piga et al.’s
(13) systematic review on feasibility, effectiveness, and patient
satisfaction with telemedicine for patients with rheumatic disease
identified three studies involving patients with juvenile idiopathic
arthritis (JIA). Two of the studies were self-management studies
and one was an education study; therefore, remote disease activity
assessment was not performed on these studies (14–16). An
abstract published in 2014 surveying 77 pediatric rheumatology
practices reported that seven sites had telemedicine capabilities,
but only three sites actively used telemedicine to see patients (17).
Another study at one center reported that families preferred inperson to telemedicine visits, though most of the respondents
were unfamiliar with telemedicine (9). The rate of telemedicine
acceptance appeared to increase with greater familiarity with this
medium (9). Despite the evidence suggesting telemedicine could
result in potential cost savings, the adoption of telemedicine
remained low for the reasons mentioned above (8). An abstract
published in 2018 reported on the experience of providing
pediatric rheumatology care over telemedicine using a mixed
model (10). Patients traveled to a site close to their home with
telemedicine capabilities, where they connected virtually with
their pediatric rheumatologist while having a hands-on joint
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MATERIALS AND METHODS
The Pediatric Rheumatology Care and Outcomes Improvement
Network (PR-COIN) is a quality improvement collaborative
learning network of 21 pediatric rheumatology medical centers
and parent/patient stakeholders across the United States and
Canada (20). Together, they partner to identify and close gaps
in healthcare for children with rheumatic diseases by leveraging
quality improvement science and to bring research discoveries
to patient care promptly (20). In addition, the Network strives
to disseminate the knowledge gained to the wider community
through education and publication of results (21). Participating
sites are focused on improving the outcomes of care for children
with rheumatic diseases (21).
In light of the rapid adoption of telemedicine in pediatric
rheumatology, members of the PR-COIN Tele-Rheumatology
Workgroup conducted an electronic survey. The main goal of
this survey was to gather information reflecting each center’s
experiences during the COVID-19 pandemic, specifically related
to telemedicine, including their rates of adoption, how visits were
being conducted, and their opinions of seeing patients using this
medium (see Supplementary Material for survey).
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at each site) (Table 1). Teams included pediatric rheumatologists,
trainees, nurses, practitioners (nurse/ACPAC), allied health
professionals (e.g., medical assistant, social workers, dietitian,
physical therapist, occupational therapist), and physicians
from other subspecialties such as adolescent medicine and
dermatology. The smallest site was composed of four pediatric
rheumatologists, whereas the largest site was composed of 11
pediatric rheumatologists, one nurse practitioner, two medical
assistants, six nurses, six fellows, four physical therapists, two
occupational therapists, and one social worker.

TABLE 1 | Composition of Healthcare Team at PR-COIN Sites.
Type of Members on Healthcare Team

Number
of Sites

Pediatric rheumatologists, trainees, nurses, practitioners
(nurse/ACPAC)

3

Pediatric rheumatologists

2

Pediatric rheumatologists, trainees, nurses, allied health
(medical assistants)

2

Pediatric rheumatologists, nurses, practitioners
(nurse/ACPAC), allied health (medical assistants)

2

Pediatric rheumatologists, nurses, allied health (physical
therapist/practical nurse/social worker)

2

Pediatric rheumatologists, trainees, nurses

2

Pediatric rheumatologists, nurses

1

Pediatric rheumatologists, trainees

1

Pediatric rheumatologists, nurses, allied health (social
worker, physical therapist), specialists from other
departments

1

Pediatric rheumatologists, trainees, practitioners
(nurse/ACPAC), allied health (medical assistant)

1

Pediatric rheumatologists, trainees, nurses, practitioners
(nurse/ACPAC), allied health (medical assistant/physical
therapist/occupational therapist/social worker)

1

Pediatric rheumatologists, trainees, practitioners
(nurse/ACPAC), nurses, allied health (physical
therapist/social worker/dietitian), specialists from other
departments

1

Telemedicine Adoption and Utilization
Of the 18 centers with completed responses, only four centers
(21%) reported conducting telemedicine visits prior to the
COVID-19 pandemic. However, telemedicine was previously
utilized to service <10% of the four center’s population. All 18
responding sites indicated that they were able to successfully
adopt telemedicine visits during the COVID-19 pandemic. The
switch from in-person to telemedicine services occurred midMarch for 10/18 (55%) of the centers, while the remaining
centers switched mid to late March (Figure 1). At its peak, 16/18
(89%) reported seeing 75–100% of visits were conducted using
telemedicine. As some sites began phased reopening (seeing
patients in person) during late spring of 2020, the use of
telemedicine subsequently decreased. All sites reported using
telemedicine to see both new referrals and follow-up patients.

ACPAC, Advanced Clinician Practitioner in Arthritis Care; PR-COIN, Pediatric
Rheumatology Care and Outcomes Improvement Network.

Telemedicine Platforms
The most commonly reported platform used to conduct
telemedicine visits was Zoom (7/19), followed by American
Well (5/19). Sites also indicated that they used Microsoft
Teams, FaceTime, Doximity, and Ontario Telemedicine Network
(OTN) (2/19). Other rarely reported platforms included Jabber,
WhatsApp, SBR Health, Bluejeans, and WebEx (1/19). The
majority of sites (11/19) reported using MyChart as their patient
portal. This was followed by HealthELife (3/19), FollowMyHealth
(2/19), and one unspecified patient portal.

The survey was sent to the lead investigator at each PR-COIN
center. They were requested to complete the survey within a
1 week period during June 2020. Survey data were collected
and managed using REDCap R electronic data capture tool
(22, 23). REDCap R is a secure, web-based software platform
designed to support data capture for research studies, providing
(1) an intuitive interface for validated data capture, (2) audit
trails for tracking data manipulation and export procedures,
(3) automated export procedures for seamless data downloads
to common statistical packages, and (4) procedures for data
integration and interoperability with external sources (22, 23).
Quantitative data were analyzed using descriptive statistics.
Two independent reviewers analyzed the qualitative data using
grounded theory to provide understanding of concepts and ideas
emerging from the survey.
PR-COIN collaborative activities are covered under
an umbrella Institutional Review Board (IRB) protocol,
including member surveys that are used as part of continuing
quality improvement.

Type of Telemedicine Visits
All sites reported their ability to conduct virtual visits with both
audio and visual features (Figure 2). Here, 12/19 (63%) sites
reported using videoconferencing systems, 5/19 (26%) reported
using a combination of both videoconferencing systems and
electronic health record (EHR) patient portals, while 2/19 (11%)
sites reported using only their EHR patient portal. Moreover,
13/19 (68%) sites reported also conducting audio-only visits.
Also, 3/19 (16%) sites reported using mixed models where
patients traveled to a site close to their home with audio and video
telemedicine capabilities. These three sites were using this mixed
model prior to the COVID-19 pandemic.

RESULTS

In-Person vs. Telemedicine Visit

Center Demographics

When providers were asked about reasons to see a patient
in person vs. using telemedicine, respondents indicated a
patient having active or worsening disease and requiring
additional medical care such as hospitalization or joint

The survey was completed by 19 of 21 (90%) PR-COIN centers,
but only 18 of the surveys had complete responses. Centers varied
in the size and composition of their team (range: 4–33 members
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FIGURE 1 | Use of Telemedicine Prior to and During the COVID-19 Pandemic. Each color represents a different center.

reporting <50% completion, 5/19 (26%) sites reporting 50–75%
completion, 5/19 (25%) sites reporting 76–100% completion,
and the four remaining sites did not respond to this question.
PROs that were able to be obtained verbally, such as morning
stiffness or patient global assessment, were more reliably collected
than Patient-Reported Outcome Measures (PROMs), which are
generally longer validated questionnaires.

injections, coordinating collaborative care, or upon patient
request (Table 2).

Effect on Patient Volume
The majority of centers [14/19 (74%)] reported that their patient
volumes had decreased as a result of switching to telemedicine
during COVID-19, while 4/19 (21%) reported that their volumes
were about the same. One site was not certain about whether their
patient volumes had been affected.

Documentation
The reliability of providers documenting items is described in
Table 4. Medication reconciliation, medication refills, and date
of last eye examination were the items that were the most
frequently documented. Conversely, height and weight were the
least documented items.

Assessment of Joint Disease Activity
Most centers [13/19 (68%)] reported that at least 50% of their
providers consistently used the pediatric Gait, Arms, Legs, Spine
tool (pGALS) to perform joint activity assessments in patients
with JIA (Figure 3). The pGALS is a structured musculoskeletal
exam that has been used and validated in multiple languages
to identify musculoskeletal abnormalities in children during inperson assessments (24).

Items Patients Received Prior to the
Telemedicine Visit
The instructions provided to patients to prepare for their
telemedicine visit varied from site to site. Consent was also
obtained by some sites prior to their appointment. Patient
instructions were e-mailed, mailed, or provided verbally. Patients
would receive an e-mail link for the telemedicine appointment or
notification by their patient portal. Two sites offered mock visits
to ensure that patients knew how to connect. Some nurses and
medical assistants are connected with patients prior to their visit
to gather pre-visit information.

Patient-Reported Outcomes
Patient-reported outcomes (PROs) were collected by most
sites (Table 3). Here, 15/19 (79%) sites reported collecting
duration of morning stiffness. Multi-item PROs questionnaires,
e.g., Child Health Assessment Questionnaire (CHAQ), or
Patient-Reported Outcomes Measurement Information System
(PROMIS) measures were collected by a small minority of
centers (5–11%). The majority of sites reported verbally collecting
PROs during the telemedicine appointment [16/19 (84%)]. In
addition, 3/19 (16%) sites reported collecting PROs using their
patient portals, 2/19 (11%) sites reported collecting PROs using
e-mail, and 1/19 (5%) sites indicated they also had a custom
system built during the COVID-19 pandemic to collect PROs.
The PRO completion rate varied widely, with 5/19 (26%) sites

Frontiers in Pediatrics | www.frontiersin.org

Items Patient Received After the
Telemedicine Visit
The majority of respondents indicated that patients received
prescriptions 18/19 (95%), referrals 16/19 (84%), and aftervisit summary 13/19 (68%) at the end of their telemedicine
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(16%) indicated that they provided it by fax. One respondent
indicated that pertinent items were faxed directly to the recipient,
e.g., pharmacy or other clinics.

Research During Telemedicine Visits
With respect to conduct of research activities over telemedicine,
7/19 (36%) sites reported conducting research activity during
this period, while 8/19 (42%) reported that they were unable to
conduct research. Of the sites reporting the ability to conduct
research during the COVID-19 pandemic, only 2/7 (14%) sites
reported being able to obtain consent over telemedicine. Most
of the research that continued was follow-up visits for registries
where information could be abstracted from charts or clinical
personnel were able to assist with a portion of the research
process. Coordinating research during this time relied more
heavily on communication with the clinical team and the clinical
team’s willingness to assist with activities.

Benefits and Challenges to Use of
Telemedicine
Benefits noted with telemedicine included improved
convenience, no need to travel, continuity of care for families
who were hesitant to have in-person appointments, and the
ability to see patients in their natural environment (Table 5).
Challenges noted with telemedicine included limited ability to
perform physical exams, difficulties assessing disease activity,
and difficulties accessing and utilizing technology (Table 6).
All respondents agreed telemedicine visits met both provider
and patient needs. All respondents also indicated that they
believed that the use of telemedicine visits should continue
following the resolution of the COVID-19 state of emergency. At
the time of survey, most centers 14/19 (74%) felt that <50% of
established patients and 15/19 (79%) new patients could be safely
and effectively seen over telemedicine moving forward.

FIGURE 2 | Mediums Used to Perform Telemedicine Visits. (A) Medium Usage
by Sites. (B) Sites Usage of Mediums. Note: Bar graph answers are not
mutually exclusive.

DISCUSSION

TABLE 2 | Reasons for In-Person Visit Preferred Over Telemedicine Visit.
Joint injection

89%

Anticipate hospitalization

74%

Worsening condition

68%

Evidence of new rheumatic disease

63%

Active disease

58%

Parent request/desire

53%

New patient

47%

Other

16%

Need for laboratory visits

5%

Telemedicine has facilitated the continuity of care to pediatric
rheumatology patients while reducing the risk of transmission of
COVID-19 among healthcare providers, patients, and caregivers.
To our knowledge, this is the first survey assessing the
change in telemedicine practices in pediatric rheumatology
due to the COVID-19 pandemic. Not only has telemedicine
facilitated the continuity of care in pediatric rheumatology,
but it has also been successfully adapted by other pediatric
subspecialties including adolescent medicine, otolaryngology,
and sleep medicine (25–27).
In light of the need to quickly respond during the pandemic,
a variety of platforms were used to conduct telemedicine visits.
With the adaptation and normalization of telemedicine into
clinical practice, healthcare teams have since moved toward
ensuring that telemedicine visits are conducted using private and
secure [e.g., Health Insurance Portability and Accountability Act
(HIPAA)/Personal Health Information Protection Act (PHIPA)
compliant] healthcare information exchange platforms. Some
institutions have invested in infrastructure to conduct these
visits such as webcams and software that integrate virtual visits

appointment. Additional items that were provided included
requisitions for external labs [4/19 (21%)], physiotherapy
resources [2/19 (11%)], requisition for external diagnostic
imaging [1/19 (5%)], and disease-specific information
[1/19 (5%)].
Patients generally received these materials through their
patient portal [12/19 (63%)] or by mail [12/19 (63%)]. Also, 8/19
(42%) sites reported sending this information by e-mail, and 3/19

Frontiers in Pediatrics | www.frontiersin.org
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FIGURE 3 | Percentage of Providers from Each Site Using pGALS to Assess Joint Disease Activity during Telemedicine Visits.

TABLE 3 | Patient-Reported Outcomes Documented During Telemedicine Visit.

TABLE 4 | Items Documented During a Telemedicine Visit.

Morning stiffness

79%

Medication reconciliation

95%

Patient global assessment

68%

Medication refills

95%

Pain intensity

58%

Date of last eye examination

95%

Patient self-reported joint count

26%

Visit conducted using telemedicine

79%

Do not collect any patient-reported outcomes (PROs)

11%

Allergy review

79%

Child Health Assessment Questionnaire (CHAQ)

11%

Laboratory results

79%

Other

11%

Physician Global Assessment

74%

Patient-Reported Outcomes Measurement Information
System (PROMIS)

5%

Patient Global Assessment

74%

Joint count

68%

Juvenile Arthritis Multidimensional Assessment Report
(JAMAR)

5%

Patient-Reported Outcomes

53%

Pediatric Quality of Life InventoryTM (PedsQL)

Disease activity (e.g., JADAS)

42%

0%

Treatment target(s)

37%

Weight

26%

Height

0%

into patients’ EHRs. Although the enactment of the National
Emergencies Act in the United States and telehealth expansion
in Canada helped overcome some barriers of reimbursement
and HIPAA, it did not address the issue of reimbursement and
providing telemedicine services to patients residing in another
state (interstate licensure) or another country (28, 29).
Although our results indicated that all sites had the ability
to conduct visits with audio and video capability, we do not
know what proportion of visits were conducted audio-only
consultations vs. audio and video consults.
Despite the availability of telemedicine, providers recognized
circumstances where patients should be seen in person,
suggesting that there may be a need to systematically triage
patients to determine whether they should be seen in person

Frontiers in Pediatrics | www.frontiersin.org

or over telemedicine. This process may require additional time
and preparation of the healthcare and administrative team. To
our knowledge, there currently are no recommendations or
guidelines on how to best triage pediatric rheumatology patients,
which may warrant future investigations.
The reasons for changes in patient volumes during the
COVID-19 pandemic are not specifically known. Possible
explanations for decreased volumes include family reluctance
to leave home during the pandemic, declined visit bookings,
limited access or resources of families to conduct telemedicine
visits, and caregiver’s occupation and changes in work schedule.
It is also not clear whether telemedicine visits are longer in
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Given that our survey found that about half of the sites’
teams used pGALS to assess their patients over telemedicine,
it is possible that not all healthcare providers are aware of or
trained in the use of the pGALS joint activity assessment tool.
As such, there is an opportunity to train providers so they
are aware of tools that may assist them during their physical
assessment of patients. Similarly, should a tool be validated for
performing assessment over telemedicine, it is important that
the knowledge be disseminated to educate providers, which will,
in turn, standardize care among pediatric rheumatology patients
over telemedicine.
PROs are an integral part of routine clinical practice and
contribute to a myriad of studies (31). The documentation of
patient global assessments was reportedly low. This may be
due to several factors including the reliance of the healthcare
provider to ask the patients to rank the state of their rheumatic
condition on a scale of 0–10 and then documenting the response.
During the initial adoption of telemedicine, healthcare providers
may have prioritized learning how to provide care using this
medium and, therefore, may have elected to focus on completing
items that they deemed to be a higher priority. With increased
familiarity of delivering care over telemedicine platforms, it is
possible that PRO collection and documentation have increased.
Furthermore, as a proportion of patients will continue being
seen over telemedicine after the pandemic is over, it would be
worthwhile to implement a method to reliably collect PROMs for
these visits.
The variability in the documentation of items during
telemedicine visits compared to in-person visits may be due
to several factors. Some variations may be accounted for by
local billing, compliance, and/or institutional requirements. It
appeared that information that the providers had more ease
and control of obtaining, such as medication reconciliation, was
more reliably documented, whereas other pieces of information
that required some effort of patients and their caregivers (e.g.,
measuring height) or other measuring tools (e.g., weight scale)
were less reliably documented. As telemedicine will continue
to serve a proportion of patients, healthcare providers should
consider how to equip families that may not have a scale
or, less commonly, a stadiometer, on how to reliably collect
these measurements. Providing educational resources to patients
and families as well as communicating alternative methods to
accomplish these measurements might be a feasible option. Most
families have access to smartphones where they could download
applications that may help them perform measurements or
access websites, such as the Centers for Disease Control and
Prevention (CDC), which have instructional guidelines (32, 33).
Clinical support tools (such as Smart Phrases, note templates,
and billing templates) embedded in the EHR may assist in
reminding healthcare providers to document exam elements
during telemedicine visits.
Given that everyone was expected to adapt to telemedicine
rapidly and the lack of guidance documents at the outset of
the pandemic, instructions provided to patients (if any were
provided) varied in everyone’s practice (even within sites). Since
then, some guidance documents have been developed, but there
are none specific to pediatric rheumatology (34). It would be

TABLE 5 | Benefit of Telemedicine Visits.
No travel

95%

More convenient

84%

Continuity of care for families who are hesitant to come
for in-person visits

84%

Less cancellations/no shows

58%

Decreased patient wait times (i.e., shorter time to
schedule an appointment)

53%

Decreased clinic visit length (i.e., time spent with
healthcare provider)

42%

Other (e.g., opportunity to observe a patient’s home
environment)

5%

TABLE 6 | Challenges of Telemedicine Visits.
Limited ability to perform physical exams

89%

Assessing disease activity

84%

Access to technology

68%

Safety labs being performed at recommended interval

53%

Adequate Internet bandwidth

47%

Providing multidisciplinary care

42%

Patient education

32%

Communicating after-visit instructions/making follow-up
visits

26%

Licensure

11%

Reimbursement

5%

Other-Miscellaneous technological issues for the
patients/providers

5%

duration or if the learning curve of conducting telemedicine visits
affected scheduling volumes. Furthermore, patients may have
limited ability to be seen over telemedicine because they might
not have the bandwidth, resources, or knowledge of how to access
telemedicine visits. We do not know how many new referrals
each site receives annually or how many patients with JIA are
serviced annually, therefore we cannot predict how large of a
clinical volume is seen by healthcare providers at each site, which
may affect their comfort level with using telemedicine.
Although most centers reported that some of their providers
used the pGALS to assess joint activity, this tool has not been
validated for use over telemedicine. As a result, healthcare
providers may not be confident in the accuracy of active joint
activity assessment when utilizing this tool over this telemedicine.
The instrument also may not be able to identify small effusions
or detect active joints in young children when used over
telemedicine. Recently, Shenoi et al. (30) proposed the VideopGALS (an adapted version of the pGALS), but this has not
been validated and was created using input from a small group
of pediatric rheumatologists. Additional research needs to be
undertaken to determine whether this tool can accurately assess
joint disease activity in a virtual setting. If it is determined that
this tool is valid, it could enable the standardization of care over
telemedicine. Conversely, if it is not valid, pediatric healthcare
providers will need to seek other means of performing accurate
joint disease activity assessments.
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worthwhile to look at the current practices among different
sites to collectively learn from each other and create a best
practice document. Surprisingly, some caregivers do not realize
that patients needed to be present for telemedicine appointments
or understand the importance of creating an environment to
conduct the visit. The development of a best practice document
with unified expectations and instructions may assist patients and
caregivers to better prepare for their appointment.
Providing requisitions for external laboratory and
diagnostic testing after the telemedicine visit offers patients
more convenience as they can maintain continuity of
care while not traveling too far from their home. Only
one site reported providing patients with disease-specific
information. It is not clear whether this was because it was
an open-ended question and respondents did not think
of this answer, or whether other providers did not have
digitized resources to send to their patients. With the shift
to telemedicine, healthcare teams should consider amassing
digital resources that they can provide to their patients
and families.
Many institutions limited research activities during the
COVID-19 pandemic to reduce the number of staff entering their
facilities as well as prioritize the ethical approval of COVID-19related research activities (35). To ensure that scholarly work
continues, it is important to establish mechanisms in which
research can be performed over telemedicine (36). This will
require developing and operationalizing a plan that is amenable
to both healthcare and research teams. In addition, using virtual
workflows such as digital consent forms and electronic case
report forms will facilitate research activities over telemedicine.
Naturally, there will be additional costs associated with these
changes, and funders of research will need to avail additional
funding to facilitate this transition (35). Researchers will need
to include a telemedicine/virtual visit component within their
future research budgets. Furthermore, to ensure diversity and
inclusiveness, researchers will also need to consider ways to
facilitate the participation of individuals who do not have access
to technological tools.
Given that patients did not have to travel to attend their
telemedicine visit, households saved time and money associated
with traveling to see their healthcare provider. Not much is
about the cost of pediatric rheumatology telemedicine visits,
e.g., Internet data compared to in-person visits, e.g., traveling.
It would be worthwhile to explore the economic impacts of
these visits. Telemedicine visits offer an alternative solution to
overcoming clinician shortages, especially in rural and other
underserved populations. In pediatric rheumatology, where there
is a clear workforce shortage and states without providers, there
is a distinct opportunity to reduce travel-associated costs (8, 37)
and ensure regularity of follow-up for patients, which is critical
in pediatric chronic care. The convenience of telemedicine could
have potentially brought back patients who were not seen in
a long time because they were in remission and did not want
to lose time and money to travel to their healthcare provider
only to be told they were fine. As such, the use of telemedicine
can improve the outcomes of patients with pediatric rheumatic
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conditions, as it increases access to, as well as facilitates,
continuity of care.
The challenge of telemedicine is that it may be not be
equally accessible to everyone. There remain certain regions
with poor bandwidth and minimal Internet services (38). Due
to socioeconomic circumstances, some families may not be able
to afford the cost associated with these types of appointments.
Further work is needed to elucidate the effect of socioeconomic
status, language, broadband availability, and technologic literacy
on patient access.
Although all respondents indicated that telemedicine met
their needs, future work should consider assessing their
satisfaction with telemedicine visits. Another item worth
assessing is the learning curve associated with telemedicine
visits or any additional stress associated with the switch to
this medium.
The limitations of our study include that the participants were
North American pediatric rheumatologists who were members of
PR-COIN, therefore limiting the generalizability of our findings.
PR-COIN sites are generally large pediatric research centers
that have extensive experience conducting collaborative research.
Future studies could be conducted on an international level to
assist with the generalizability of the results. In addition, since
this was distributed to PR-COIN site leaders, we are uncertain
whether the results accurately reflect the opinions of all the
providers at their site or whether they were responding based on
personal experience. For sites reporting the use of telemedicine
prior to the COVID-19 pandemic, we do not know whether
this prior experience was equal among all staff members and
whether this facilitated a quicker transition to telemedicine for
the remainder of their practice. Furthermore, as this survey
asked providers to reflect at a single point in time, opinions may
have shifted over time with increased experience with the use
of telemedicine. We are currently developing a follow-up survey
to see whether healthcare providers’ opinions have changed with
time and experience and identify what novel ideas and tools have
emerged ∼1 year after mass the adoption of telemedicine. This
will enable us to identify best practices. With the identification
and implementation of best practices, future studies will be able
to observe how disease monitoring over telemedicine changes
over time.
Our survey only asked about the use of pGALS as an
assessment tool and did not inquire about other tools providers
used to assess joint disease activity over telemedicine. We plan to
identify other tools that healthcare providers are using to assess
joint disease activity, so that if a reliable method is uncovered,
the knowledge can be shared with pediatric rheumatology
healthcare providers.
Finally, this survey was only administered to healthcare
providers and not patients and caregivers. Therefore, we
do not have an understanding of telemedicine visits from
their perspective. Future projects should include patients’
and caregivers’ perspectives in order to help understand
their needs and barriers and what influences their decisions
when selecting appointment mediums. It would also be
informative to know how comfortable caregivers would
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feel if they were asked to actively assist in the physical
examination process.

PR-COIN collaborative activities are covered under an umbrella
Institutional Review Board (IRB) protocol at Cincinnati
Children’s Hospital Medical Center. Member surveys are used
as part of continuing quality improvement. Written informed
consent to participate was therefore not required for this study
in accordance with the institutional requirements.

CONCLUSIONS
The COVID-19 pandemic accelerated the change to delivering
care over telemedicine. This survey indicates that rapid
adaptations occurred to facilitate the implementation of pediatric
rheumatology clinical care and research over telemedicine in
response to the COVID-19 pandemic. In doing so, they were able
to continue providing medical care to pediatric rheumatology
patients despite the physical distancing requirements. Given
that all sites were able to transition to providing care over
telemedicine, the prospect of continuing this practice in the
future is highly likely given that most institutions have added
resources and infrastructure during the COVID-19 pandemic.
We identified specific challenges healthcare providers faced
when conducting visits over telemedicine, such as the limited
number of available tools to reliably perform assessments,
the lack of certainty with these evaluations, and ensuring
that patients had access to technology in order to conduct
telemedicine visits. Further research is needed to identify and
validate tools that can reliably be used to perform assessments
over telemedicine, identify mechanisms to improve provider
documentation, identify ways to improve the collection of PROs,
create standardized instructions to better prepare patients for a
successful telemedicine visit, and identify ways to best integrate
research visits along with telemedicine visits. Most importantly,
we need to ensure that telemedicine can be delivered in a safe,
supportive, and accessible way to pediatric rheumatology patients
and their families.
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